From Discretion to Regulation: What FDA’s Final Rule Means for Laboratory Developed Tests
Hall Render
JUNE 5, 2024
In April 2024, the Food and Drug Administration (“FDA”) issued a Final Rule amending the definition of in vitro diagnostics products (“IVDs”) found in 21 C.F.R. The FDA notes that it will continue to exercise enforcement discretion during the review of premarket submissions received by this stage.
Let's personalize your content